Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice - PubMed (original) (raw)

. 2004 Apr 1;103(7):2610-6.

doi: 10.1182/blood-2003-03-0835. Epub 2003 Nov 20.

Affiliations

• PMID: 14630814
• DOI: 10.1182/blood-2003-03-0835

Free article

Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice

Bing-Qiao Zhao et al. Blood. 2004.

Free article

Abstract

Cerebral hemorrhage associated with antithrombotic and thrombolytic therapy in acute stroke continues to present a major clinical problem. Rupture of the cerebral microvasculature involves the degradation and remodeling of extracellular matrix. Here we demonstrated that the delayed administration of heparin 3 hours after photothrombotic middle cerebral artery occlusion (MCAO) caused cerebral hemorrhage in wild-type (WT) mice but not in tissue plasminogen activator (tPA)-deficient knockout (KO) mice. Heparin administration increased tPA activity and its mRNA expression at 6 and 12 hours after MCAO in the ischemic hemispheres of WT mice. The expression of tPA was enhanced in microglial cells in the ischemic border zone. We also observed an exacerbation of matrix metalloproteinase (MMP) 9 expression at the mRNA level and its conversion to an active form after heparin administration in the ischemic hemisphere in WT mice but not in tPA KO mice. The increased MMP 9 expression was localized in microglial cells and endothelial cells. These findings suggest that endogenous tPA, through the enhancement of MMP 9 expression and proteolytic activation, plays an essential role in the pathogenesis of heparin-produced cerebral hemorrhage. Targeting tPA, MMP 9, or both may provide a new approach for preventing cerebral hemorrhage associated with antithrombotic therapy for stroke in humans.

PubMed Disclaimer

Similar articles

• [Role of endogenous tPA in stroke].
  Umemura K. Umemura K. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Aug;25(4):183-8. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005. PMID: 16190367 Review. Japanese.
• Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
  Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH. Tsuji K, et al. Stroke. 2005 Sep;36(9):1954-9. doi: 10.1161/01.STR.0000177517.01203.eb. Epub 2005 Jul 28. Stroke. 2005. PMID: 16051896
• Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
  Zhang C, An J, Haile WB, Echeverry R, Strickland DK, Yepes M. Zhang C, et al. J Cereb Blood Flow Metab. 2009 Dec;29(12):1946-54. doi: 10.1038/jcbfm.2009.174. Epub 2009 Aug 12. J Cereb Blood Flow Metab. 2009. PMID: 19672275
• Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
  Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Wang X, et al. Stroke. 2004 Nov;35(11 Suppl 1):2726-30. doi: 10.1161/01.STR.0000143219.16695.af. Epub 2004 Sep 30. Stroke. 2004. PMID: 15459442 Review.

Cited by

• Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage.
  Hou ST, Nilchi L, Li X, Gangaraju S, Jiang SX, Aylsworth A, Monette R, Slinn J. Hou ST, et al. Sci Rep. 2015 Jan 20;5:7890. doi: 10.1038/srep07890. Sci Rep. 2015. PMID: 25601765 Free PMC article.
• Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia.
  Martinez G, Musumeci G, Loreto C, Carnazza ML. Martinez G, et al. J Mol Histol. 2007 Aug;38(4):295-302. doi: 10.1007/s10735-007-9102-9. Epub 2007 Jun 6. J Mol Histol. 2007. PMID: 17551674
• RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats.
  Zheng YQ, Liu JX, Li XZ, Xu L, Xu YG. Zheng YQ, et al. Acta Pharmacol Sin. 2009 Jul;30(7):919-27. doi: 10.1038/aps.2009.79. Acta Pharmacol Sin. 2009. PMID: 19574998 Free PMC article.
• A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.
  Gu Z, Cui J, Brown S, Fridman R, Mobashery S, Strongin AY, Lipton SA. Gu Z, et al. J Neurosci. 2005 Jul 6;25(27):6401-8. doi: 10.1523/JNEUROSCI.1563-05.2005. J Neurosci. 2005. PMID: 16000631 Free PMC article.
• The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke.
  Nakano K, Hokamura K, Taniguchi N, Wada K, Kudo C, Nomura R, Kojima A, Naka S, Muranaka Y, Thura M, Nakajima A, Masuda K, Nakagawa I, Speziale P, Shimada N, Amano A, Kamisaki Y, Tanaka T, Umemura K, Ooshima T. Nakano K, et al. Nat Commun. 2011 Sep 27;2:485. doi: 10.1038/ncomms1491. Nat Commun. 2011. PMID: 21952219 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program